Triple-Negative Breast Carcinoma — Research

Triple-Negative Breast Carcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-14	15,965	`("Triple Negative Breast Neoplasms"[mh] OR "Breast Cancer, Triple-Negative"[mh] OR "ER Negative PR Negative HER2 Negative Breast Cancer"[mh] OR "ER Negative PR Negative HER2 Negative Breast Neoplasms"[mh])`	2026-09-14	pubmed
Last 5 years	2021-01-01 → 2026-12-31	9,775	`("Triple Negative Breast Neoplasms"[mh] OR "Breast Cancer, Triple-Negative"[mh] OR "ER Negative PR Negative HER2 Negative Breast Cancer"[mh] OR "ER Negative PR Negative HER2 Negative Breast Neoplasms"[mh]) AND (2021/01/01:2026/12/31[dp])`	2026-09-14	pubmed
Last 12 months	2025-09-14 → 2026-09-14	2,107	`("Triple Negative Breast Neoplasms"[mh] OR "Breast Cancer, Triple-Negative"[mh] OR "ER Negative PR Negative HER2 Negative Breast Cancer"[mh] OR "ER Negative PR Negative HER2 Negative Breast Neoplasms"[mh]) AND (2025/09/14:2026/09/14[dp])`	2026-09-14	pubmed

Data updated 16 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (5)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–5 of 5 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
· N Engl J Med · 2021 · PMID 34081848 · validated civic_curation pubmed
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer.
· J Clin Oncol · 2015 · PMID 25847936 · validated civic_curation pubmed
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study.
· Lancet Oncol · 2011 · PMID 21862407 · validated civic_curation pubmed
Targeting Akt3 signaling in triple-negative breast cancer.